Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-01
1997-10-07
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530322, C07K 1436, A61K 3100
Patent
active
056748370
ABSTRACT:
A method of stabilizing bleomycin solutions and to the stable bleomycin solutions resulting therefrom are described. In the method described, bleomycin solution is stabilized by solubilizing bleomycin powder in an aqueous solution and storing the solution at reduced temperature while it awaits use.
REFERENCES:
Meyers et al., "Preparation . . . Bleorycin", J. Nucl. Med., vol. 16(9) Sep. 835-8 (1975). Abstract.
Yokoyama et al., "The importance . . . 99mTC Sleorycin", Int. J. Appl. Radiat. Isof., vol. 2 (9-10) pp. 549-555 (1978). Abstract.
Adams, et al., American Journal of Hospital Pharmacy; "Instability of Bleomycin in Plastic Containers", vol. 39, pp. 1636, published Oct., 1982.
Aszalos, et al., Journal of Pharmaceutical Sciences; "High-Performance Liquid Chromatographic Determination of Components of Bleomycin Preparations", vol. 70, No. 8, pp. 878-880, published Aug. 1981.
Benvenuto, et al., American Journal of Hospital Pharmacy; "Stability Compatibility of Antitumor Agents in Glass and Plastic Containers", vol. 38, pp. 1914-1918, published Dec. 1981.
Crooke, et al., Journal of Medicine; "Bleomycin, A Review", vol. 7, No. 5, pp. 333-339, published 1976.
Dalton-Bunnow, et al., American Journal of Hospital Pharmacy, "Update on room-temperature stabiltiy of drug products labeled for refrigerated storage", vol. 47, pp. 2522-2524, published Nov. 1990.
Dorr, et al., Journal of Medicine, "Bleomyicn Compatibility with Selected Intravenous Medications", vol. 13, Nos. 1&2, pp. 121-130, published 1982.
Koberda, et al., American Journal of Hospital Pharmacy, "Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers", vol. 47, pp. 2528-2529, published Nov., 1990.
MeadJohnson, Oncology Products, "Blenoxane.RTM. Sterile, Bleomycin sulfate", USP, published Mar., 1988.
Trissel LA, et al., Handbook of Injectable Drugs, American Society of Hospital Pharmacists, Bethesda, MN, pp. 69-72, published 1986.
D'Arcy, PF, Letter, Comment on handling of anticancer drugs, Drug Intelligence and Clinical Pharmacy, 18, p. 417, published 1984.
Travenol Laboratories, Inc., "TCX Premix Chemical Stability Dting", published Aug. 26, 1987.
Gupta Pramod K.
Kirkpatrick Gayle A.
Abbott Laboratories
Hannum David C.
Touzeau Lynn
Tsang Cecilia J.
Woodworth Brian R.
LandOfFree
Stable bleomycin sulfate solution suitable for injection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable bleomycin sulfate solution suitable for injection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable bleomycin sulfate solution suitable for injection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357344